v3.26.1
Investments (Tables)
12 Months Ended
Mar. 31, 2026
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Investments
Investments consist of the following:
March 31,
20262025
Equity method investments in Funds$567,888 $453,636 
Other equity method investments— 386 
Fair value investments— 12,190 
Measurement alternative investments206,555 198,142 
Total Investments$774,443 $664,354 
Schedule of Variable Interest Entities
Investments of Consolidated Funds and Partnerships consist of the following:
March 31,
20262025
Equity method investments in Funds$20,841 $19,292 
Fair value investments505,237 77,408 
Total Investments of Consolidated Funds and Partnerships$526,078 $96,700 
The following table presents the assets and liabilities of consolidated VIEs that are included in the Consolidated Balance Sheets.
March 31,
20262025
Assets of Consolidated Funds and Partnerships:
Cash and cash equivalents$— $48,112 
Investments487,357 96,700 
Other assets9,516 460 
Total assets$496,873 $145,272 
Liabilities of Consolidated Funds and Partnerships:
Subscriptions in advance$55,561 $— 
Other liabilities12,902 922 
Total liabilities$68,463 $922 
The carrying value of assets and liabilities recognized in the Consolidated Balance Sheets related to the Company’s interests in these non-consolidated VIEs and the Company’s maximum exposure to loss relating to non-consolidated VIEs were as follows:
March 31,
20262025
Investments$284,958 $256,350 
Fees receivable43,607 48,601 
Due from related parties7,573 4,723 
Total VIE assets336,138 309,674 
Non-controlling interests(2,190)(2,497)
Maximum exposure to loss$333,948 $307,177 
Schedule of Equity Method Investments
The Company’s equity method investments in Funds consist of the following types:
March 31,
20262025
Primary funds$39,972 $35,251 
Secondary funds70,601 60,545 
Direct investment funds100,116 94,257 
Customized separate accounts163,090 141,088 
Evergreen funds194,109 122,495 
Total equity method investments in Funds$567,888 $453,636 
The summarized financial information of the Company’s equity method investments in Funds is as follows:
March 31,
20262025
Assets
Investments$59,976,551 $50,486,273 
Other assets2,231,251 1,242,238 
Total assets$62,207,802 $51,728,511 
Liabilities and Partners’ Capital
Debt$369,438 $494,430 
Other liabilities851,571 741,822 
Total liabilities1,221,009 1,236,252 
Partners’ capital60,986,792 50,492,259 
Total liabilities and partners’ capital$62,207,801 $51,728,511 
Year Ended March 31,
202620252024
Investment income$916,410 $870,828 $625,176 
Expenses531,670 487,339 403,517 
Net investment income384,740 383,489 221,659 
Net realized and unrealized gain4,470,303 1,690,743 2,672,499 
Net income$4,855,043 $2,074,232 $2,894,158 
Schedule of Equity Securities without Readily Determinable Fair Value
The following table summarizes the activity related to the Company’s measurement alternative investments:
Year Ended March 31,
202620252024
Carrying amount, beginning of the year$198,142 $175,522 $168,732 
Adjustments related to equity investments
Purchases8,000 13,853 6,311 
Sales / return of capital — — (176)
Net change in unrealized gain (loss)1
413 8,767 1,177 
Net realized loss— — (522)
Carrying amount, end of year$206,555 $198,142 $175,522 
(1) Net change in unrealized gain (loss) consists of fair value adjustments for observable price changes of identical or similar investments.
Schedule of Cumulative Gross Unrealized Gains(Loss)
The following table summarizes the cumulative gross unrealized gains and cumulative gross unrealized losses related to the Company’s measurement alternative investments:
As of March 31,
202620252024
Cumulative gross unrealized gains$79,414 $79,002 $70,235 
Cumulative gross unrealized losses $(43,289)$(43,289)$(43,289)